In patients with high bleeding risk, 1 vs. ≥3 mo of DAPT after complex or noncomplex PCI did not differ for clinical events.
Where this comes from
- Record sourced from PubMed, PMID 36191320.
- Also identified by DOI 10.7326/J22-0076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Valgimigli M, Smits PC, Frigoli E, et al. <b>Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.</b> Eur Heart J. 2022:43:3100-14. 35580836.
Medical subject headings
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors